Skip to content

The clinical success of the permanent posterior filling alternative Equia ®

The clinical success of the permanent posterior filling alternative Equia ®

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00004220
Enrollment
440
Registered
2012-09-06
Start date
2010-09-01
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

K02

Interventions

Group 1: Filling with a conventional Glasionomer (Fuji IX GP fast + Fuji Coat LC®) Group 2: Filling with a modified Glasionomer + Coat (EQUIA System)

Sponsors

GC Europe N.V.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Dentate patients, no partial or full dentures, proximately three opposing zones with occlusal contacts of natural teeth in the posterior region

Exclusion criteria

Exclusion criteria: Patients with CMD dysfunction or malfunction (signs of occlusal abrasion, hyperfunction, clenching) will be excluded from the study. CMD-Screening form according to DGZMK record. Participants, who may not be willing to sign the consent form, will be withdrawn to take part in the clinical investigation (according to Declaration of Helsinki and ICH E6 (R1) GCP Guidelines, July 2002).

Design outcomes

Primary

MeasureTime frame
Survival rate of the compared two arms in a 5 year follow up according to a calibrated evaluation based on FDI standard (Hickel et al 2010) beginning from baseline

Secondary

MeasureTime frame
Failure rate of all fillings

Countries

Germany

Contacts

Public ContactThomas Klinke

Poliklinik f. Prothetik und Werkstoffkunde Ernst-Moritz-Arndt-Universität

klinke@uni-greifswald.de03834-867140

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Mar 2, 2026